Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: A systematic review and Meta-Analysis (2007–2017)

BACKGROUND: Limitations have been observed with the use of clopidogrel following percutaneous coronary intervention (PCI) indicating the urgent need of a more potent anti-platelet agent. We aimed to compare the efficacy and safety of ticagrelor versus clopidogrel following PCI. METHODS: Online datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Wenjun, Lu, Hongtao, Yang, Keping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221558/
https://www.ncbi.nlm.nih.gov/pubmed/30412125
http://dx.doi.org/10.1097/MD.0000000000012978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221558/
https://www.ncbi.nlm.nih.gov/pubmed/30412125
http://dx.doi.org/10.1097/MD.0000000000012978

Ejemplares similares